Used in biomedical research to quantify levels of Human Topoisomerase II beta (TOP2b) protein in cell lysates, tissue extracts, and biological samples. Enables researchers to study TOP2b expression in various physiological and pathological conditions, including cancer, neurodegenerative diseases, and cardiac development. Supports investigation into the effects of drugs and environmental factors on TOP2b activity, particularly in studies involving DNA damage, chromatin remodeling, and chemotherapy response. Widely applied in molecular biology and pharmacology labs for high-throughput screening and biomarker validation.